REVENUE

12 Months Ended

Dec. 31, 2020

REVENUE

REVENUE

NOTE 8 - REVENUE

The following table summarizes the Company’s disaggregation of revenues:

	Year Ended December 31,
(U.S. dollars in thousands)	2018		2019		2020
Pfizer	$	5,320	$	6,722	$	8,105
Brazil	$	3,658	$	9,144	$	8,000
Chiesi		-		-	$	131
Total revenues from selling goods	$	8,978	$	15,866	$	16,236
Revenues from license and R&D services	$	25,262	$	38,827	$	46,662

During the year ended December 31, 2020, the Company recorded revenue in the amount of $12.8 million following a change in estimate of the total costs expected to be incurred in the connection with the Chiesi Agreements.